Le Lézard
Classified in: Business
Subjects: SHAREHOLDER RIGHTS PLANS, MERGERS AND ACQUISITIONS (M&A)

Federal Court approves convening of Scheme Meeting and dispatch of Scheme Booklet


BRISBANE, Australia, Nov. 08, 2023 (GLOBE NEWSWIRE) -- Allkem Limited (ASX: AKE, "Allkem" or the "Company") is pleased to provide the following update in relation to the proposed merger of equals between Allkem and Livent Corporation ("Livent"), announced to ASX on 10 May 2023 ("Transaction").

Court Approval

The Federal Court of Australia has today made orders:

Scheme Booklet

The Scheme Booklet will be released to ASX and sent to Allkem shareholders following registration with the Australian Securities and Investments Commission ("ASIC"). It will also be available on Allkem's website at https://www.allkem.co/.

The Scheme Booklet will include a copy of the Independent Expert's Report, which has been prepared by Kroll Australia Pty Ltd.

The Scheme Booklet will be dispatched to Allkem Shareholders as follows:

Allkem Shareholders should carefully read the Scheme Booklet in its entirety, including the materials accompanying it, before deciding whether to vote in favour of the Scheme.

Scheme Meeting

The Scheme Meeting will be held at The Studio, Level 2, Crown Towers, Crown Perth Convention Centre, Great Eastern Highway, Burswood, Western Australia 6100, on 19 December 2023 commencing at 10:30am (AWST) / 1:30pm (AEDT). Allkem shareholders can also attend the Scheme Meeting virtually, via the online platform at https://meetnow.global/MUHNARQ.

Further details of how to access the online platform and participate in the Scheme Meeting online will be contained in the Notice of Scheme Meeting included in the Scheme Booklet, and the Computershare Online Meeting Guide that is included in the Notice of Scheme Meeting.

Each Allkem shareholder who is registered on the Allkem register at 7:00 pm (AEDT) on 17 December 2023 is entitled to attend and vote at the Scheme Meeting. All Allkem shareholders are encouraged to vote by completing and returning the proxy form, or by attending the Scheme Meeting in person (including online, or by proxy, attorney or corporate representative).

Indicative Scheme Timetable

The key dates expected for the Transaction are set out below. Allkem will continue to update shareholders about any material developments in relation to the Transaction or the indicative timetable for the Transaction, as the timetable progresses.

Date / timeEvent
15 November 2023Completion of Scheme Booklet dispatch
10:30am (AWST) / 1:30pm (AEDT) on 17 December 2023Latest time and date for receipt of proxy forms for Scheme Meeting
7:00pm (AEDT) on 17 December 2023Time and date for determining eligibility to vote at the Scheme Meeting
10:30am (AWST) / 1:30pm (AEDT) on 19 December 2023Scheme Meeting
If the Scheme is approved by Allkem Shareholders (and the US Merger is approved by Livent Stockholders)
20 December 2023Second Court Date for approval of the Scheme
21 December 2023Scheme Effective Date
7.00pm (AEDT) on 27 December 2023Record Date for determining entitlements to receive Scheme Consideration
4 January 2024Scheme Implementation Date
Scheme Consideration issued to Eligible Shareholders
4 January 2024 (New York time)US Merger Effective Time
NewCo Shares issued to Livent Stockholders after this time


Note:
All references to time above are references to AEDT (Sydney time), unless otherwise specified.

All dates following the date of the Scheme Meeting are indicative only and, among other things, are subject to all necessary approvals from the Court and other Governmental Entities and the satisfaction or permissible waiver of all other applicable closing conditions. Allkem reserves the right to vary the times and dates set out above. Any changes to the above timetable (which may include an earlier Second Court Hearing) will be announced through ASX, filed under Allkem's profile on SEDAR+ and notified on www.allkem.co.   

This release was authorised by the Board of Directors of Allkem Limited.

Allkem Limited

ABN 31 112 589 910

Level 35, 71 Eagle St
Brisbane, QLD 4000
Investor Relations & Media Enquiries

Andrew Barber
M: +61 418 783 701 E: [email protected]

Phoebe Lee
P: +61 7 3064 3600 E: [email protected]
Connect

[email protected]
+61 7 3064 3600
www.allkem.co


IMPORTANT NOTICES

Not for release or distribution in the United States

This announcement has been prepared for publication in Australia and may not be released to U.S. wire services or distributed in the United States. This announcement does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States or any other jurisdiction, and neither this announcement or anything attached to this announcement shall form the basis of any contract or commitment. Any securities described in this announcement have not been, and will not be, registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States except in transactions registered under the U.S. Securities Act of 1933 or exempt from, or not subject to, the registration of the U.S. Securities Act of 1933 and applicable U.S. state securities laws.



These press releases may also interest you

at 08:10
Coincheck Group N.V. ("Coincheck Group," the "Company" or "Group"), a Dutch public limited liability company and a holding company of Coincheck, Inc. ("Coincheck"), a leading Japanese crypto exchange company, today reported financial results for its...

at 08:10
NCR Atleos Corporation ("Atleos") will release fourth quarter and full year 2024 financial results after the market close on Monday, March 3, 2025. Management will host a conference call to discuss results on Tuesday, March 4 at 8:30 a.m. Eastern...

at 08:08
A groundbreaking immersive video experience for fans at the Las Vegas Grand Prix has been awarded the 2025 Lumiere Award for Best Interactive Experience by the Advanced Imaging Society....

at 08:06
Trading resumes in: Company: Dominion Lending Centres Inc. TSX Symbol: DLCG All Issues: Yes Resumption (ET): 8:00 AM CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading...

at 08:05
Quantum-Si Incorporated ("Quantum-Si," "QSI" or the "Company"), The Protein Sequencing Companytm, today announced that it will report financial results for the fourth quarter and full year 2024 on Monday, March 3, 2025. Jeff Hawkins, President and...

at 08:05
Zevia PBC ("Zevia") today announced that it will release its financial results for the fourth quarter and full year 2024 ended December 31, 2024 before the market open on Wednesday, February 26, 2025 followed by a conference call at 8:30 a.m....



News published on and distributed by: